Clinical Trial Update: Clinical Trial of Autologous Tcm Immunotherapy in ICC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for autologous Tcm immunotherapy in cholangiocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• autologous Tcm immunotherapy

Snippet

Sponsor: Newish Technology (Beijing) Co., Ltd. | Conditions: Cholangiocarcinoma | Phase 2 | Status: UNKNOWN